Endocrine Impairments in Primary Mitochondrial Disorders: A Clinical Review
Overview
Primary mitochondrial disorders (PMD) are genetic conditions affecting mitochondrial function, leading to diverse endocrine impairments. Diabetes is the most common endocrine manifestation, with other possible dysfunctions including growth hormone deficiency, adrenal insufficiency, hypogonadism, and parathyroid abnormalities.
Background
Mitochondria are essential organelles responsible for energy production and multiple biosynthetic functions, including steroidogenesis. PMDs arise from genetic defects in mitochondrial or nuclear DNA, affecting mitochondrial structure or function. Given mitochondria's role in hormone production and secretion, endocrine organs are susceptible to dysfunction in PMD. Understanding these endocrine manifestations is critical for timely diagnosis and management of affected patients.
Data Highlights
PMD has an estimated birth prevalence of at least 1 in 4300. Over 400 genes across mitochondrial and nuclear genomes have been implicated. Mitochondrial DNA mutations exhibit heteroplasmy, influencing disease severity and organ involvement. Endocrine manifestations vary by disorder and organ, with diabetes being the most frequent.
Key Findings
Diabetes mellitus is the most frequent endocrine manifestation in PMD patients.
Other endocrine dysfunctions include growth hormone deficiency, adrenal insufficiency, hypogonadism, and parathyroid gland abnormalities.
Thyroid dysfunction is not strongly linked causally to PMD despite the thyroid's metabolic role.
PMD inheritance involves both mitochondrial DNA (maternally inherited) and nuclear DNA, complicating genetic patterns.
Heteroplasmy and threshold effects in mtDNA mutations lead to variable clinical presentations and organ involvement.
Diagnosis requires high clinical suspicion, especially when endocrine symptoms coexist with unrelated comorbidities.
Clinical Implications
Clinicians should consider PMD in patients presenting with endocrine abnormalities, particularly diabetes, when accompanied by multisystemic features or unusual comorbidities. Early recognition and thorough endocrine evaluation in known PMD patients are essential to optimize management. Genetic testing and next-generation sequencing can aid diagnosis, guiding personalized treatment approaches.
Conclusion
Endocrine dysfunction is a significant and varied component of primary mitochondrial disorders, reflecting the central role of mitochondria in hormone biosynthesis and secretion. Improved understanding and recognition of these impairments can facilitate timely diagnosis and targeted management in this complex patient population.
References
Author/Source/Year -- Endocrine Impairments Associated with Primary Mitochondrial Disorders
